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Abstract
Background: Tuberculosis (TB) is a contagious disease affected by multiple genetic and environmental factors. Several
association studies have suggested that cellular immune response is vital for controlling and preventing of tuberculosis
infection. Low molecular weight polypeptides (LMPs) and transporters with antigen processing (TAPs) are the main
molecules in the processing and presentation pathway for intracellular antigens. This study was performed to elucidate
whether these antigen-processing genes (LMP/TAP) polymorphisms could be associated with the risk of tuberculosis
infection in China.
Methodology/Principal Findings: We recruited 205 active pulmonary tuberculosis patients and 217 normal controls from Li
population for this study. Four polymorphisms of LMP/TAP genes were determined by PCR-RFLP assay and haplotypes were
constructed by software PHASE 1.0. Of the total four polymorphisms, genotype frequencies of LMP7 AA homozygote and
CA heterozygote were significantly greater among cases compared to controls, with odds ratio of 3.77 (95% CI: 1.60–8.89;
P=0.002) and 2.97 (95% CI: 1.80–4.90; P,0.0001), respectively. The genotypes of TAP1-2 GG homozygote and AG
heterozygote were more frequent in subjects with TB than in controls, with odds ratio of 3.94 (95% CI: 1.82–8.53; P=0.001)
and 2.87 (95% CI: 1.75–4.71; P,0.0001), respectively. Similarly, we found that haplotype B which carried LMP7 and TAP1-2
variations significantly increased the susceptibility to TB (OR=3.674, 95% CI: 2.254–5.988; P,0.0001). Moreover, it is
noteworthy that the homozygote of wild haplotype A (A/A) may be a strong protection for TB infection.
Conclusions: Our findings suggested that LMP/TAP gene polymorphisms might be risk factors for TB infection among Li
population in China.
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Introduction
Tuberculosis (TB), the leading cause of morbidity and mortality
by a single infectious agent, is still a major health problem in the
world. According to the annual report on global control of TB
from WHO, about 9.4 million incident cases and 14 million
prevalent cases occurred in 2009. Approximately 1.7 million
people died of TB, including 0.38 million deaths among the HIV-
positive people, and most cases were in the South-East Asia,
African and Western Pacific regions (35%, 30% and 20%,
respectively) [1].
It is well known that host genetic susceptibility, together with
bacterial strains and environmental factors, plays an important
role in determining TB predisposition and drug response. Only
about 10% of the infected individuals develop the clinical disease
while most infected people carry the bacteria without overt
symptom [2,3]. To date, many studies have shown evidence of
association between host genetic polymorphisms and TB suscep-
tibility, including CCL2/MCP-1, NRAMP1/SLC11A1, IRGM1,
IL8, TLR, and NOD2 genes [4]–[][][][][9]. Most of these genes
participate in immune response and their polymorphisms may
lead to increase genetic susceptibility to TB.
The genes for low molecular weight polypeptides (LMPs) and
transporters with antigen processing (TAPs) are located within the
MHC class II region of chromosome 6 between the HLA DP and
HLA DQ loci, and have been shown to play a critical role in the
processing and presentation pathway for intracellular antigens
[10]. The LMP genes encode two subunits which form a
proteasome complex and mainly involve in the proteolysis of
certain peptides [11]. The products of TAP genes compose a
heterodimeric complex which translocates antigenic peptides from
cytoplasm into the endoplasmic reticulum for binding the major
histocompatibility complex (MHC) class I molecules for presen-
tation to CD8+ cytotoxic T cells [12]. It has been reported that
Mycobacterium tuberculosis (Mtb) protein presentation requires the
cytosolic proteasomal degradation and subsequent TAP transpor-
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presentation of Mtb antigens remain enigmatic, studies have
demonstrated that it may use multiple processing pathways
[15,16]. In addition, a previous report also revealed that TAP-
deficient mice exhibited an increased susceptibility to TB that was
manifested by a decreased survival after infection, a greater
bacterial burden, and more severe tissue pathology [17]. These
data establish that MHC Class I antigen-processing pathway
which requires cleavage of antigen peptides by LMP2/LMP7 and
transportation of peptide fragments into the endoplasmic reticu-
lum by TAP1/TAP2, is vital for controlling the Mtb infection and
preventing the development of active TB.
Several polymorphisms within the coding region of LMP and
TAP have been detected and are considered to be associated with
a number of immune diseases, viral infection diseases, and even
malignant tumors [18]–[][][][22]. A few of these polymorphisms
(TAP1 and TAP2) have been studied to determine predisposition
towards TB in different ethnic groups, which have revealed the
susceptibility to TB [23,24]. The aim of this study was to
investigate the associations between polymorphisms of LMP and
TAP genes and susceptibility to active TB disease in Li population
in Hainan province, an island of southern China in the South
China Sea. The incidence of TB was 1.5 fold in Li population than
in Han population [25]. Concurrently, we also attempted to
determine whether the haplotypes covering these SNPs were
linked to the development of TB and explored potential risk
factors for TB.
Methods
Ethics Statement
This study was approved by the Institution Review Boards of
Hainan Center for Disease Control and Prevention and the
written informed consents were obtained.
Subjects
Two hundred and five unrelated patients diagnosed with active
pulmonary TB were enrolled in this study. These patients were
followed up at Hainan Center for Disease Control and Prevention
between 2005 and 2008. The diagnosis of pulmonary TB was
based on the following criteria: 1) clinical symptom suggestive of
TB; 2) chest radiographic evidence of active pulmonary TB in the
upper lobes; 3) sputum smear positive with or without chest
radiographic evidence of active pulmonary TB; 4) excluding the
subjects with diseases such as lung carcinoma, pneumonia,
diabetes and other immunosuppressive condition. Patients with
the presence of all criteria were recruited.
The control group included 217 healthy unrelated adults
without history of TB, autoimmune diseases, or other infectious
diseases from Li population in Hainan province. The healthy
volunteers were from the general population with the same socio-
economic status and ethnic background as that of the patients, and
were selected through the population survey of tuberculosis with
PPD skin test results ,5 mm and remaining uninfected during 2
years.
All subjects of TB cases and normal controls were HIV
seronegative and BCG vaccinated. The demographic character-
istics were described in Table 1.
Genotyping analysis and haplotype construction
Genomic DNA was extracted from peripheral blood leukocytes
of study subjects by standard procedures. Polymorphisms in LMP
genes and TAP genes were genotyped using primer pairs as shown
in Table 2. The four polymorphisms were detected by polymerase
chain reaction (PCR) restriction fragment length polymorphism
(RFLP) analysis, which abide by previously described methods
[20]. The reaction was carried out in a 50 ml reaction mixture
containing 4 ml of genomic DNA, 5 mlo f1 0 6PCR buffer, 2.5 ml
of 25 mM MgCl2,1mlo f1 0mM dNTP, 1 mlo f2 0mM each
specific primers (shown in Table 1), 0.5 ml of 5 U Taq DNA
polymerase, and 36 ml of ddH2O. The PCR was performed by
denaturing at 94uC for 2 min, followed by thirty cycles as
denaturation at 94uC for 40 s, annealing at 56.5uC (LMP2) and
57uC (LMP7, TAP1-1, TAP1-2) for 40 s, extension at 72uC for
40 s, and the final extension at 72uC for 10 min.
The amplified products were purified and then digested using
specific restriction endonuclease under the different conditions as
per the manufacturer’s instructions. After digestion, the fragments
were electrophoresed in a 2% agarose gel and were visualized by
ethidium bromide staining. The accuracy of genotyping was
confirmed by direct sequencing of the random DNA samples
(N=10) from cases and controls for all polymorphic sites. Finally,
the PHASE 1.0 software was used to construct the haplotypes for
all the four gene polymorphisms [26].
Statistical analysis
The chi-square test was used to compare genotype distribution
and allele frequency in the TB patients and control subjects with
SPSS 12.0 software packages. Hardy–Weinberg equilibrium was
tested by Haploview 4.2 software. The haplotype frequencies were
calculated with PHASE1.0 software. The associations between
case and control groups were evaluated by utilizing the
unconditional logistic regression model adjusted for gender, age,
cigarettes smoking and alcohol drinking. Odds ratio (OR) and
95% confidence interval (95% CI) were estimated and a P value of
,0.05 was considered to be significant.
Results
Characteristics of the Participants
The 205 patients with active pulmonary TB and 217 healthy
controls with PPD skin test results ,5 mm were studied. The
demographic characteristics including age, gender, cigarettes
smoking, and alcohol drinking were summarized in Table 1.
Table 1. Demographic characteristics for tuberculosis cases
and controls.
Case n=205 Control n=217
gender
male 138 105
female 67 112
age
male 42.20617.35 26.86612.64
female 41.27615.63 27.63615.17
smoke
male 43 30
female 2 2
drink
male 45 32
female 3 1
BCG Vaccinated Yes Yes
doi:10.1371/journal.pone.0033051.t001
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selected the non-infected individuals as control subjects in this
preliminary study.
Correlation of Genetic Polymorphisms and Tuberculosis
According to the previous studies of LMP/TAP gene polymor-
phisms of other diseases [20,22], we selected four non-synonymous
coding SNP. Genotypes (homozygote and heterozygote) were
confirmed by using restriction fragment length polymorphism
(RFLP) method according to different numbers of enzyme
fragments. Table 2 listed the SNPs that were selected including
their rs numbers and PCR amplification primers.
The genotype distributions for these four polymorphisms did not
deviate significantly from Hardy-Weinberg equilibrium in both case
and control groups. Table 3 listed the allele and genotype
frequencies for all the polymorphisms. Allele frequencies for three
polymorphism loci (TAP1-1/TAP1-2/LMP7) were revealed to
have significant differences between the TB patients and controls
(P,0.01). The genotype frequencies of LMP7 AA homozygote and
CA heterozygote were significantly greater among cases compared
to the healthy control group, with odds ratio of 3.77 (95% CI: 1.60–
8.89; P=0.002) and 2.97 (95% CI: 1.80–4.90; P,0.0001),
respectively. Similarly, the genotype of TAP1-2 GG homozygote
and AG heterozygote were more frequent in subjects with TB than
in controls, with odds ratio of 3.94 (95% CI: 1.82–8.53; P=0.001)
and 2.87 (95% CI: 1.75–4.71; P,0.0001), respectively.
Of the other two polymorphisms, the prevalence of the TAP1-1
AG heterozygote was more significantly found in cases than in
controls (OR=1.92, 95% CI: 1.19–3.12, P=0.008), while the
frequency of GG homozygote had no considerable difference
between the two groups (P=0.583). In the LMP2 polymorphic
site, no significant difference was observed in the distribution
among cases and controls (P.0.05).
Considering the difference in gender distribution between case
and control groups, we further analyzed our data by separating
malesand females.Similarresultswereobtainedwhensampleswere
stratifiedby gender. Significantassociationswere observed inLMP7
and TAP1-2 polymorphism sites with either allelic or genotypic
analysis (P,0.01). There was a little difference detected for TAP1-1
site in which male showed a trend of association but not in female
group (Table 4). Therefore, the possible exerted confounding effect
due to difference in gender distribution may be excluded.
Association of Haplotype with Tuberculosis
To study the combined effects of the four polymorphic sites in
LMP/TAP genes, we next carried out the haplotypic association
analysis. The statistical software PHASE 1.0 was used to estimate
differences in the haplotype frequencies, which calculated
haplotype frequencies with an expectation maximization algo-
rithm. A total of thirteen haplotypes (A-M) were constructed, and
all of the haplotypes were found in both case and control groups.
The distribution of different haplotypes in each group was
summarized in Table 5.
Among the thirteen haplotypes observed in the 205 TB
patients and 217 controls recruited for the study, only three
haplotypes represented at frequencies .5% (Table 5). These
three haplotypes together accounted for .69.9% of the total
haplotypes in both case and control groups. Thus, these
haplotypes were selected to assess the susceptibility to TB
(Table 6).
We noticed these three haplotypes had relatively low frequen-
cies with homozygote haplotypes, which may increase the
inaccuracy of haplotype frequency estimation and lead to false-
positive inference. Hence, we incorporated the homozygote and
heterozygote of each haplotype and evaluated the association of
global haplotype distributions with TB. The results showed that
only haplotype B significantly associated with tuberculosis in our
study population (OR=3.674, 95% CI=2.254–5.988,
P,0.0001), as depicted in Table 7. No significant differences
were observed in the other two haplotypes between the two
groups.
Discussion
As the second country with the largest number of incidence
cases in the world, China is still facing great challenges to TB
control. Though the incidence rate has slowly reduced from 99
(per 100 000 population) in 2005 to 96 (per 100 000 population) in
2009, the absolute number of cases continues to increase slightly
from year to year [1]. Li population is the only minority
nationality lived in Hainan province, with a total population of
1.28 million in 2010. The rate of smear-positive TB was 13.1% in
Li population, compared to 9.9% in Han population [25]. Besides
the socio-economic factors such as living condition, poverty,
treatment delay and poor-quality care, host genetic susceptibility
may be another significant risk factor for influencing TB incidence
in different population.
In the present study, we focused on the association of
polymorphic sites in LMP/TAP genes with TB susceptibility in
Li population. We tested four polymorphisms in the coding
regions of LMP2, LMP7 and TAP1 genes and observed all the
polymorphisms in the subjects enrolled in our study. The
polymorphism of LMP2 gene (rs17587) was reported as the
Table 2. Primer sets used for amplification and sequencing of LMP/TAP gene.
Gene Code
position variant rs # missense PCR primers (sense/antisense) Length (bp)
Annealing
temperature
LMP2 C/T rs17587 ArgRCys 59-CTCCACTTTACAGATGCAGA-39 330 56.5uC
(CGCRTGC) 59-ACTTGGTGACTGTTGACTCC-39
TAP1-1 A/G rs1057141 IleRVal 59-GCAGGTAACATCATGTCTCG-39 430 57.0uC
(ATCRGTC) 59-GACAGATTGTGGGGAGAAGC-39
TAP1-2 A/G rs1135216 AspRGly 59-CAGTAGTCTTGCCTTTATCC-39 405 57.0uC
(GACRGGC) 59-ATGACTGCCTCACCTGTAAC-39
LMP7 C/A rs2071543 GlnRLys 59-TCATGGCGCTACTAGATGTATG-39 351 57.0uC
(CAGRAAG) 59-AACTCTTTGTCCTAACTTGCAC-39
doi:10.1371/journal.pone.0033051.t002
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histidine at this locus in any of the cases or controls. Instead, a
cysteine replacement was observed in this population which was
consistent with previous studies [20,22]. These findings suggested
that LMP and TAP polymorphisms may differ among populations
as reported by other studies.
Table 3. Genotype, allele frequencies of the polymorphisms in the LMP and TAP genes.
Gene Allele Cases n (%) Controls n (%) P Value Genetype Cases n (%) Controls n (%) P Value* OR*(95% CI)
LMP2
C 321 (78.29) 347 (79.95) CC 124 (60.49) 135 (62.21) —
T 89 (21.71) 87 (20.05) 0.553 CT 73 (35.61) 77 (35.48) 0.691 1.33 (0.33–5.33)
TT 8 (3.90) 5 (2.30) 0.770 0.93 (0.58–1.49)
TAP1-1
A 299 (72.93) 352 (81.11) AA 104 (50.73) 147 (67.74) —
G 111 (27.07) 82 (18.89) 0.005 AG 91 (44.39) 58 (26.73) 0.008 1.92 (1.19–3.12)
GG 10 (4.88) 12 (5.33) 0.583 0.74 (0.25–2.18)
TAP1-2
A 240 (58.54) 322 (74.19) AA 66 (32.20) 121 (55.76) —
G 170 (41.46) 112 (25.81) ,0.0001 AG 108 (52.68) 80 (36.87) ,0.0001 2.87 (1.75–4.71)
GG 31 (15.12) 16 (7.37) 0.001 3.94 (1.82–8.53)
LMP7
C 240 (58.54) 314 (72.35) CC 59 (28.78) 110 (50.69) —
A 170 (41.46) 120 (27.65) ,0.0001 CA 122 (59.51) 94 (43.32) ,0.0001 2.97 (1.80–4.90)
AA 24 (11.71) 13 (5.99) 0.002 3.77 (1.60–8.89)
Significant p values are in bold.
*Logistic regression model, adjusted by gender, age, smoke and drink.
doi:10.1371/journal.pone.0033051.t003
Table 4. Genotype, allele frequencies and sex specific association analysis.
Gene and sex n Allele frequency (%) P Value Genotype frequency (%) P Value*
LMP2 C T CC CT TT
M Case 138 213 (77.17) 63 (22.83) 81 (58.69) 51 (36.96) 6 (4.35)
Control 105 173 (82.38) 37 (17.62) 0.159 70 (66.67) 33 (31.43) 2 (1.90) 0.561
F Case 67 108 (80.60) 26 (19.40) 43 (64.18) 22 (32.84) 2 (2.98)
Control 112 174 (77.68) 50 (22.32) 0.513 65 (58.03) 44 (39.29) 3 (2.68) 0.856
TAP1-1 A G AA AG GG
M Case 138 197 (71.38) 79 (28.62) 67 (48.55) 63 (45.65) 8 (5.80)
Control 105 178 (84.76) 32 (15.24) 0.0005 78 (74.29) 22 (20.95) 5 (4.76) 0.014
F Case 67 102 (76.12) 32 (23.88) 37 (55.22) 28 (41.79) 2 (2.99)
Control 112 174 (77.68) 50 (22.32) 0.734 69 (61.61) 36 (32.14) 7 (6.25) 0.324
TAP1-2 A G AA AG GG
M Case 138 160 (57.97) 116 (42.03) 43 (31.16) 74 (53.62) 21 (15.22)
Control 105 158 (75.24) 52 (24.76) ,0.0001 62 (59.05) 34 (32.38) 9 (8.57) ,0.0001
F Case 67 80 (59.70) 54 (40.30) 23 (34.33) 34 (50.75) 10 (14.92)
Control 112 164 (73.21) 60 (26.79) 0.008 59 (52.68) 46 (41.07) 7 (6.25) 0.047
LMP7 C A CC CA AA
M Case 138 158 (57.25) 118 (42.75) 38 (27.54) 82 (59.42) 18 (13.04)
Control 105 154 (73.33) 56 (26.67) 0.0002 55 (52.38) 44 (41.90) 6 (5.72) 0.001
F Case 67 82 (61.19) 52 (38.81) 21 (31.34) 40 (59.70) 6 (8.96)
Control 112 160 (71.43) 64 (28.57) 0.045 55 (49.11) 50 (44.64) 7 (6.25) 0.025
Significant p values are in bold.
*Logistic regression model, adjusted by gender, age, smoke and drink.
doi:10.1371/journal.pone.0033051.t004
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and TB was observed when we compared our active TB patients
and controls. The subjects containing LMP7 AA homozygote and
CA heterozygote were found to be strongly associated with TB
infection (OR=3.77, 2.97, respectively). Similarly, the TAP1-2
polymorphism also exhibited a significant relation to TB infection.
For the other two polymorphisms, no statistical significant
associations were found at polymorphic sites of LMP2 and
TAP1-1 genes to the risk of TB (Table 3). Similar to the individual
SNPs, we also observed that haplotype B which carried LMP7 and
TAP1-2 variations significantly increased the susceptibility to TB.
Moreover, it is noteworthy that the homozygote of wild haplotype
A (A/A) may be a strong protection on TB infection (Table 6). All
these results indicated that the LMP7 and TAP1 gene polymor-
phisms might be risk factors for TB infection among Li population.
The critical roles of the LMP/TAP genes are consistent with the
observed association for TB in our study. LMP is a cytosolic
proteinase complex which hydrolyzes antigens into 8- or 9-residue
peptides, and TAP is a member of the ATP-binding cassette
transporter family which translocates antigenic fragments to MHC
class I molecules in the endoplasmic reticulum. Previous studies
have reported that LMPs proteasomes favor to promote cleavage
of peptides after hydrophobic and basic residues but suppress
cleavage after acidic residues. This effect results in the generation
of peptides that preferentially ended with hydrophobic or basic
carboxyl termini [28]. Furthermore, the polymorphisms located at
TAP1/TAP2 gene coding region may affect the specificity of
peptide presentation [29,30]. Therefore, the interaction of LMP
and TAP genes polymorphisms may subsequently interfere with
the LMP/TAP-dependent translocation of disease associated
peptides.
It is worth mentioning that the LMP and TAP genes are located
close and centromeric to the HLA-DQB1 gene in chromosome 6
MHC class II region [31]. The MHC is the most gene-dense
region of the human genome sequenced. It also encodes most
polymorphic human proteins, some of which have over 200 allelic
variants. Considering that strong linkage disequilibrium exists
between HLA-DR and HLA-DQ genes, the strong associations for
LMP7 and TAP1 genes might also be in linkage disequilibrium
with HLA-DQB1 gene in our population. This hypothesis should
be verified in the further study.
In 1997, Rajalingam R and colleagues first reported a statistical
association between alleles in TAP2 region with pulmonary
tuberculosis and tuberculoid leprosy susceptibility in the North
India populations [23]. In contrast to our study, no significant
differences in the prevalence of TAP1 alleles were observed. In
addition, another recent study carried out in a Northwestern
Colombian population also failed to detect any association of
TAP1 gene with TB disease [24]. There may be several reasons for
the discrepancy between our findings and those reported results.
Recently, Stein took a systematic review from a genetic
epidemiological perspective. She illustrated the key influencing
factors for the inconsistency in TB literature, such as the
phenotype definition both in cases and controls, population
differences-more than just geography, complex genetic effects,
Table 5. Haplotypes frequencies of the LMP/TAP genes in
cases and controls.
Haplotypes
Loci
[LMP2][TAP1-1][TAP1-2]
[LMP7]
Cases
n( % )
Controls
n( % )
Number of chromosome 410 (100) 434 (100)
A CAAC 138 (33.66) 229 (52.76)
B CAGA 97 (23.66) 52 (11.98)
C TGAC 40 (9.76) 34 (7.83)
D TAGA 9 (2.20) 26 (5.99)
E CGGA 19 (4.63) 14 (3.23)
F CAAA 15 (3.66) 18 (4.15)
G CGAC 11 (2.68) 19 (4.38)
H CGAA 23 (5.61) 7 (1.61)
I CAGC 18 (4.39) 8 (1.84)
J TGGC 18 (4.39) 8 (1.84)
K TAAC 6 (1.46) 12 (2.76)
L TAGC 9 (2.20) 4 (0.92)
M TAAA 7 (1.71) 3 (0.69)
doi:10.1371/journal.pone.0033051.t005
Table 6. Haplotypes distributions of the LMP/TAP genes in
cases and controls.
Haplotypes Case n Control n
CAAC=A
–/–
a 67 68
–/A 138 69
A/A 0 80
CAGA=B
–/– 108 166
–/B 97 50
B/B 0 1
TGAC=C
–/– 165 184
–/C 40 32
C/C 0 1
a– denotes any haplotype, for example: –/A indicates the A haplotype in
combination with any other haplotype.
doi:10.1371/journal.pone.0033051.t006
Table 7. Distribution of haplotype frequencies in LMP/TAP
genes among cases and controls.
Haplotypes Case n (%) Control n (%) P Value
a OR (95% CI)
CAAC=A
–/–
b 67 (32.7) 68 (31.3) ----
–/A+A/A 138 (67.3) 149 (68.7) 0.867 0.960 (0.594–1.551)
CAGA=B
–/– 108 (52.7) 166 (76.5) ----
–/B+B/B 97 (47.3) 51 (23.5) ,0.0001 3.674 (2.254–5.988)
TGAC=C
–/– 165 (80.5) 184 (84.8) ----
–/C+C/C 40 (19.5) 33 (15.2) 0.317 1.358 (0.745–2.474)
aLogistic regression model, adjusted by gender, age, smoke and drink.
b– denotes any haplotype, for example: –/A indicates the A haplotype in
combination with any other haplotype.
doi:10.1371/journal.pone.0033051.t007
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Another study by Chang et al also mentioned that polymorphisms
in different genes could affect antigen presentation to the same
extent and therefore compensate for each other [33]. Our study
was conducted in ethnically matched 205 active TB patients and
217 normal healthy controls recruited from the same population.
Both the single SNP and the haplotype analyses supported the
observed association of TB susceptibility. But on the other hand,
there are also some limitations should be kept in mind. First, we
couldn’t differentiate the latent tuberculosis infection (LTBI)
versus active TB disease, which previous studies have showed
that some genes may differ between the two disease statuses [34]–
[][36]. Second, limited number of studies in the haplotype
stratified analysis made the detection of small differences difficult.
Third, although we analyzed our data by separating males and
females and obtained similar results, the difference distribution in
gender was still a major pitfall in this preliminary study. A
comprehensive and systematic analysis with large sample sizes and
two stage processes of TB infection (LTBI and TB) is still in
progress.
In summary, our findings provide the first evidence of the
association between LMP gene polymorphism and human
susceptibility to TB disease. We also support the hypothesis that
MHC class I-mediated antigen presentation may play an
important role in the host defense to TB. Since the complexity
and versatility of host immune response to M. tuberculosis, further
studies with multiple genes interaction and multidisciplinary
approaches including genomic, proteomic, and immunologic data,
collectively, may better confirm the current findings.
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